MA23883A1 - Nouvelles varietes polymorphiques de dichlorhydrate de lesopitron et ses formes hydratees, processus de preparation et compositions les contenant - Google Patents

Nouvelles varietes polymorphiques de dichlorhydrate de lesopitron et ses formes hydratees, processus de preparation et compositions les contenant

Info

Publication number
MA23883A1
MA23883A1 MA24252A MA24252A MA23883A1 MA 23883 A1 MA23883 A1 MA 23883A1 MA 24252 A MA24252 A MA 24252A MA 24252 A MA24252 A MA 24252A MA 23883 A1 MA23883 A1 MA 23883A1
Authority
MA
Morocco
Prior art keywords
dichlorhydrate
lesopitron
compositions containing
preparation processes
hydrated forms
Prior art date
Application number
MA24252A
Other languages
English (en)
Inventor
Navarro Jaime Tomas
Roses Pilar Lupon
Torres Salvador Puig
Constana Jordi Frigola
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of MA23883A1 publication Critical patent/MA23883A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA24252A 1995-05-31 1996-05-29 Nouvelles varietes polymorphiques de dichlorhydrate de lesopitron et ses formes hydratees, processus de preparation et compositions les contenant MA23883A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09501086A ES2099031B1 (es) 1995-05-31 1995-05-31 Nuevos polimorfos de diclorhidrato de lesopitron y sus formas hidratadas, procedimientos de preparacion y composiciones que los contienen.

Publications (1)

Publication Number Publication Date
MA23883A1 true MA23883A1 (fr) 1996-12-31

Family

ID=8290585

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24252A MA23883A1 (fr) 1995-05-31 1996-05-29 Nouvelles varietes polymorphiques de dichlorhydrate de lesopitron et ses formes hydratees, processus de preparation et compositions les contenant

Country Status (29)

Country Link
US (1) US5872125A (fr)
EP (1) EP0771798A1 (fr)
JP (1) JPH10503532A (fr)
CN (1) CN1076020C (fr)
AR (1) AR003952A1 (fr)
AU (1) AU699210B2 (fr)
BG (1) BG62966B1 (fr)
CA (1) CA2196425A1 (fr)
CO (1) CO4700461A1 (fr)
CZ (1) CZ24797A3 (fr)
EE (1) EE9700067A (fr)
ES (1) ES2099031B1 (fr)
GE (1) GEP20002241B (fr)
HU (1) HUP9700284A3 (fr)
IL (1) IL118494A0 (fr)
IN (1) IN186820B (fr)
IS (1) IS4420A (fr)
MA (1) MA23883A1 (fr)
MX (1) MX9700792A (fr)
NO (1) NO310073B1 (fr)
NZ (1) NZ308110A (fr)
PL (1) PL318280A1 (fr)
RU (1) RU2178789C2 (fr)
SK (1) SK12697A3 (fr)
TR (1) TR199600455A2 (fr)
UY (1) UY24241A1 (fr)
WO (1) WO1996038439A1 (fr)
YU (1) YU32396A (fr)
ZA (1) ZA964139B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6869970B2 (en) 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2642759B1 (fr) * 1989-02-09 1991-05-17 Laboratorios Esteve Sa Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante
FR2654621B1 (fr) * 1989-11-22 1994-09-23 Esteve Labor Dr Inhibition du syndrome d'abstinence.
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
FR2671972B1 (fr) * 1991-01-25 1995-03-03 Esteve Labor Dr Utilisation de derives 1-h-azole-(omega-(4-(2-pyrimidinyl)-1-piperazinyl)-alkyl) pour la preparation de medicaments destines au traitement des troubles des fonctions cognitives.
FR2673628B1 (fr) * 1991-03-07 1993-07-09 Esteve Labor Dr Procede de preparation de derives d'aryl (ou heteroaryl)-piperazinyl-butyl-azoles.
FR2705098B1 (fr) * 1993-05-10 1995-08-04 Esteve Labor Dr Procédé de préparation de 2-{4-[4-(chloro-1-pyrazolyl)butyl]1-pipérazinyl}pyrimidine (Lesopitron) .

Also Published As

Publication number Publication date
GEP20002241B (en) 2000-09-25
PL318280A1 (en) 1997-06-09
IS4420A (is) 1997-01-29
CA2196425A1 (fr) 1996-12-05
WO1996038439A1 (fr) 1996-12-05
AU5765096A (en) 1996-12-18
UY24241A1 (es) 1996-06-14
HUP9700284A3 (en) 1998-01-28
CN1076020C (zh) 2001-12-12
IL118494A0 (en) 1996-09-12
CZ24797A3 (en) 1997-05-14
CN1158128A (zh) 1997-08-27
AU699210B2 (en) 1998-11-26
RU2178789C2 (ru) 2002-01-27
EE9700067A (et) 1997-10-15
BG101176A (en) 1997-08-29
HU9700284D0 (en) 1997-04-28
AR003952A1 (es) 1998-09-30
NO970392D0 (no) 1997-01-29
EP0771798A1 (fr) 1997-05-07
BG62966B1 (bg) 2000-12-29
IN186820B (fr) 2001-11-17
ES2099031A1 (es) 1997-05-01
MX9700792A (es) 1997-05-31
HUP9700284A2 (en) 1997-11-28
NZ308110A (en) 1997-08-22
NO310073B1 (no) 2001-05-14
CO4700461A1 (es) 1998-12-29
ZA964139B (en) 1997-02-06
TR199600455A2 (tr) 1996-12-21
ES2099031B1 (es) 1997-12-01
US5872125A (en) 1999-02-16
JPH10503532A (ja) 1998-03-31
YU32396A (sh) 1999-07-28
NO970392L (no) 1997-04-01
SK12697A3 (en) 1997-07-09

Similar Documents

Publication Publication Date Title
MA24466A1 (fr) Compositions contenant de la tetrahydrolistatine
MA23961A1 (fr) Benzylaminopiperidines substituees et compositions les contenant
IL117035A (en) Paroxetine hydrochloride anhydrate substantially free of bound propan-2-ol processes for its preparation and pharmaceutical compositions containing it
IL117631A (en) Polysubstituted condensed di (and tri) cyclic heterocyclic compounds their production and pharmaceutical compositions containing them
ITRM960810A0 (it) Composizioni farmaceutiche contenenti ciclosporine o macrolidi
DE69524365D1 (de) Verfahren zur Isolierung und Reinigung von 2'-Deoxy-2',2'-difluornucleosiden
DZ2361A1 (fr) Dérivés de 6-phénylpyridyl-2-amine et compositionspharmaceutiques les contenant
DE69508859D1 (de) Verfahren zur Reinigung von (-)-n-Isopulegol sowie gereinigtes (-)-n-Isopulegol enthaltende Zitrusparfümzusammensetzungen
DE69601765D1 (de) Extrakt von Iridaceen und Zusammensetzungen, die ihn enthalten
MA23942A1 (fr) Formulation nouvelle contenant de la paroxetine, et procede pour sa preparation
DE69509624D1 (de) Verfahren zur Herstellung von 1-(2'-Deoxy-2',2'-difluoro-D-ribofuranosyl)-4-amino-pyrimidin-2-on-hydrochlorid
MA23958A1 (fr) Compositions nettoyantes et desinfectantes contenant un renforcateur de desinfection electrolytique
FR2773486B1 (fr) Composition de soin des levres contenant de l'acide acexamique, ses utilisations
FR2751876B1 (fr) Utilisation d'un oligosaccharide comme immunomodulateur, composition dermato-cosmetique et methode de traitement cosmetique
TR200000291T2 (tr) Taşikinin reseptör antagonistleri olarak 2-asilaminopropanaminler.
PL322581A1 (en) Novel taxoides, method of obtaining them and pharmaceutic compositions containing them
MA23883A1 (fr) Nouvelles varietes polymorphiques de dichlorhydrate de lesopitron et ses formes hydratees, processus de preparation et compositions les contenant
FR2716374B1 (fr) Nouvelles compositions cosmétiques ou dermopharmaceutiques contenant des extraits de plantes.
EP0828520A4 (fr) Procede de criblage de composes utilises dans la prevention d'infections ou de pathogenese
PT745605E (pt) Composicoes liquidas de halogenetos de metil-estanho
LV12172A (lv) Kompozicija organu kriokonservesanai um virusu un bakterialas infekcijas arstesanai
FR2740472B1 (fr) Nouvelles souches de bacillus thuringiensis et composition pesticide les contenant
DE69602903D1 (de) Herstellung von Glaszusammensetzungen
NO981195D0 (no) Nye aminoresin sammensetninger
DZ2629A1 (fr) Formes polymorphes nouvelles de cipamfylline procédé pour leur préparation et compositions les contenant.